Your browser doesn't support javascript.
loading
Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer.
Molenaar-Kuijsten, Laura; Braal, C Louwrens; Groenland, Stefanie L; de Vries, Niels; Rosing, Hilde; Beijnen, Jos H; Koolen, Stijn L W; Vulink, Annelie J E; van Dongen, Marloes G J; Mathijssen, Ron H J; Huitema, Alwin D R; Steeghs, Neeltje.
Afiliación
  • Molenaar-Kuijsten L; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Braal CL; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • Groenland SL; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • de Vries N; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Koolen SLW; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Vulink AJE; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • van Dongen MGJ; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
  • Huitema ADR; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Steeghs N; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Clin Pharmacol Ther ; 111(2): 477-484, 2022 02.
Article en En | MEDLINE | ID: mdl-34674222
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Neoplasias de la Mama / Eritromicina / Inhibidores de Proteínas Quinasas / Inhibidores del Citocromo P-450 CYP3A / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Neoplasias de la Mama / Eritromicina / Inhibidores de Proteínas Quinasas / Inhibidores del Citocromo P-450 CYP3A / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos